Literature DB >> 26016302

Predictors of outcome in decompensated liver disease: validation of the SOFA-L score.

R ffrench-O'Carroll, S Frohlich, N Murphy, N Conlon.   

Abstract

A growing number of patients with liver disease are being referred for critical care support. We have recently shown that a combination of lactate and SOFA score (SOFA-L score) may provide an accurate, objective measurement of prognosis in a group of patients admitted to ICU with alcoholic liver disease. This score has not been validated in an independent patient cohort. A retrospective study was performed where patients admitted to our ICU with decompensated liver disease (any cause) were included. The SOFA-L score accurately predicted in-hospital mortality in this group of patients with an area under the ROC curve of 0.83. Sensitivity and specificity were 65% and 87% respectively SOFA-L performed superior to SOFA, MELD and MELD-Na scores. This study validates the use of the SOFA-L score in the initial 24 hours of ICU admission as an accurate predictor of mortality in this group of patients with a high mortality.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26016302

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis.

Authors:  M Müller; J C Schefold; A B Leichtle; D Srivastava; G Lindner; A K Exadaktylos; C A Pfortmueller
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-21       Impact factor: 0.840

2.  Disease-specific scoring or generic scoring in ICU?

Authors:  Philippe Gaudard; Pascal Colson
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  SOFA Score Plus Impedance Ratio Predicts Mortality in Critically Ill Patients Admitted to the Emergency Department: Retrospective Observational Study.

Authors:  Ashuin Kammar-García; Lilia Castillo-Martínez; Javier Mancilla-Galindo; José Luis Villanueva-Juárez; Anayeli Pérez-Pérez; Héctor Isaac Rocha-González; Jesús Arrieta-Valencia; Miguel Remolina-Schlig; Thierry Hernández-Gilsoul
Journal:  Healthcare (Basel)       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.